23andMe To Be Sold in Bankruptcy
Digest more
Regeneron is buying the assets of 23andMe, which filed for Chapter 11 bankruptcy in March after facing a series of hurdles including a data breach.
Genetics company 23andMe is expected to be purchased by Regeneron Pharmaceuticals, according to announcements shared by both companies Both companies vowed that Regeneron is committed to comply with 23andMe's privacy policies,
What happened to 23andMe? Here's a look at its history from launch to bankruptcy and acquisition by Regeneron.
Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer consumer DNA testing services.
Your 23andMe data is getting a new owner — so what are your options moving forward? The DNA testing company announced on Monday that its assets are being acquired by Regeneron Pharmaceuticals. The sale renewed concerns from some customers online about their data and how its new owner plans to use it.